Biochemical failure-free survival of 18F-rhPSMA-7 and 18F-flotufolastat PET-guided salvage radiotherapy for patients with recurrent prostate cancer
Sign Up to like & getrecommendations! Published in 2025 at "Scientific Reports"
DOI: 10.1038/s41598-024-83074-3
Abstract: Prostate-specific membrane antigen (PSMA)-targeted positron emission tomography (PET) has improved localization of prostate cancer (PC) lesions in biochemical recurrence (BCR) for salvage radiotherapy (SRT). We conducted a retrospective review of patients undergoing 18F-rhPSMA-7 or 18F-flotufolastat… read more here.
Keywords: 18f rhpsma; guided srt; 18f flotufolastat; pet ... See more keywords
Superior Diagnostic Yield of 18F-rhPSMA-7.3 Compared With 18F-DCFPyL PET/CT for the Detection of Recurrent Prostate Cancer.
Sign Up to like & getrecommendations! Published in 2025 at "Clinical nuclear medicine"
DOI: 10.1097/rlu.0000000000006200
Abstract: Prostate-specific membrane antigen (PSMA)-targeted PET imaging plays a well-established role in staging, detecting recurrence, and selecting patients for PSMA-targeted radiopharmaceutical therapy in prostate cancer. We present a case of PSMA-expressing recurrent prostate cancer in the… read more here.
Keywords: recurrent prostate; 18f rhpsma; prostate cancer; prostate ... See more keywords